February 2023 - Page 5 of 6 - CannabisNewsWire

WednesdayFeb 08, 2023 4:20 pm

420 with CNW — AMA Study Concludes Cannabis Legalization Doesn’t Increase Psychosis Prevalence

A recent study published by the American Medical Association has revealed that there has been no notable increase in the number of diagnoses for psychosis in states where cannabis is legal compared to those where it is not. To investigate the possibility that cannabis legalization could be associated with higher rates of psychosis, which some prohibitionists have used as evidence against legalization, researchers at Pennsylvania University, Stanford University and the Department of Veterans Affairs examined data on more than 63 million beneficiaries of health insurance from 2003 to 2017. The authors examined Medicare Advantage and commercial claims data in particular…

WednesdayFeb 08, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) – Technology Behind Patented Disruptive DehydraTECH(TM) Drug Delivery Platform

Lexaria has developed the DehydraTECH drug delivery technology, which enhances the performance of multiple categories of fat-soluble active molecules and drugs DehydraTECH has been shown to increase intestinal bioabsorption of certain bioactive compounds by as much as 27 times, with its onset of action being as little as 1.5 minutes The technology is also expected to lower the overall drug costs because it delivers more active molecules to the blood plasma and brain, thus necessitating lower dosing, all while resulting in cost-effective manufacturing DehydraTECH is protected by 28 patents granted worldwide, with approximately 50 more pending Speaking during a late…

WednesdayFeb 08, 2023 4:20 am

420 with CNW — FDA Passes the Buck, Gives Congress Plenty to Consider About CBD Marketing

The current tense situation regarding CBD-containing products will be maintained for the time being as a result of the U.S. Food and Drug Administration’s recent announcement that it will not regulate those products, instead delegating that responsibility to Congress. This adds to the workload for a Congress that is already becoming more acrimonious and creates more uncertainty for businesses considering entering the $4 billion-plus CBD market. Congress must make decisions regarding intoxicating cannabinoids derived from hemp, such as delta-10 THC and delta-8, in addition to tackling broader cannabis policy reform, which includes banking access, tax relief and the issue of…

TuesdayFeb 07, 2023 4:20 pm

420 with CNW — Plan to Legalize Cannabis in Germany Could Be Delayed Beyond 2024

In late October, the German government approved plans to legalize marijuana within the country’s borders. The legislation would have allowed individuals aged 18 years and older to purchase cannabis from federally licensed cannabis stores and pharmacies, possess up to 20 grams of cannabis flower and grow up to three plants at home for recreational use. At the time, officials said that the legislation’s passage depended on whether the European Commission would approve the bill. Germany’s deference to European and international bodies meant that the bill had to be in line with European and international policy before the Federal Cabinet could…

TuesdayFeb 07, 2023 10:30 am

REZYFi, Inc. Anticipates Increased Demand for its Services Following Rise in Mortgage Demand

30-year fixed-rate mortgages with conforming loan balances of $726,200 or less, saw rates decrease from 6.42% to 6.23% for the week ending January 18, 2023, resulting in a 28% increase in mortgage application volume, and a 34% increase in refinance demand It is projected that by the end of 2023, mortgage rates in the country will drop by 5.25%, coming from 2022, which saw home financing costs nearly double These rate drops present an opportunity for REZYFi to grow its customer reach, market share, and revenue but also offer an avenue for the growth of the housing finance sector REZYFi,…

TuesdayFeb 07, 2023 9:45 am

SideChannel Inc. (SDCH) Bringing Critical Security to Clients with Tailored Cybersecurity Programs for Mid-Market Companies

Brian recently joined Bell2Bell’s Stuart Smith in a podcast episode in which he discussed his and the company’s background, motivation to found SideChannel, existing market opportunities, 2022 milestones, and plans for 2023 and beyond SideChannel, a provider of cybersecurity services and products, helps mid-market companies simplify cybersecurity The company was founded in 2019 after CEO Brian Haugli observed a business opportunity in the largely underserved market Over the years since, the company has grown, posting $4.8 million in revenue in 2022, up from $2.8 million in 2021 During his stints at the US Department of Defense (“DoD”) and Pentagon, and…

TuesdayFeb 07, 2023 4:20 am

420 with CNW — USDA Unveils First-Ever Weekly Report to Boost Hemp Market

The U.S. Department of Agriculture (USDA) announced last week that it will launch a weekly newsletter to promote the country’s nascent hemp industry by providing “unbiased, timely and accurate data” on hemp. The agency released the first edition of the National Hemp Report via its Agricultural Marketing Service in tandem with the announcement. In a press release, USDA Under Secretary for Marketing and Regulatory Programs Jenny Lester Moffit stated that the USDA had seen the industry’s need for “timely market information.” She explained that the National Hemp Report would provide hemp industry stakeholders with weekly volume and price information to…

MondayFeb 06, 2023 4:20 pm

420 with CNW — FDA Throws CBD Supplements Rulemaking Duty to Congress

Despite legislative requests from stakeholders, legislators and advocates, the FDA has stated that it will not develop regulations allowing the promotion of CBD as nutritional supplements, leaving the vast industry unregulated. After conducting a "careful study" of the nonintoxicating cannabinoid, the FDA concluded that CBD won't be regulated along the same lines as food supplements. The agency stated that it would instead like to collaborate with Congress to gain a fresh perspective. Meanwhile, the FDA is also rejecting three citizen petitions that asked for rulemaking regarding CBD marketing. Days prior to this announcement, the agency issued finalized guidelines outlining the procedure…

MondayFeb 06, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) To Intensify Focus on Commercial Execution of its DehydraTECH Technology for the 2023 Calendar year

2022 saw Lexaria introduce its patented DehydraTECH(TM) technology to world-leading collaborators while also exploring DehydraTECH-CBD for the potential treatment of hypertension It also saw success in its research for the potential treatment of conditions such as epilepsy, making the year Lexaria’s most active one yet Significant progress was made on key objectives in 2022, a feat which the company plans to capitalize on and leverage to scale up the commercial execution of its technology in 2023 To facilitate this, Lexaria has brought on board Julian Gangolli, former President of GW Pharmaceuticals USA, as a strategic advisor. Chris Bunka, Lexaria’s CEO,…

MondayFeb 06, 2023 4:20 am

420 with CNW — Colorado Opens Recreational Center Built Using Cannabis Taxes

Aurora, Colorado, celebrated the official opening of its new 77,000 ft2 recreational facility on Tuesday, which cost close to $42 million. The project was fully financed by tax revenue generated by legal cannabis sales. According to KDVR news, the building is the Southeast Recreation Center and Fieldhouse and offers a variety of amenities. It includes a 23,000-foot fieldhouse with an air-conditioned interior; a complete field with turf of the highest caliber; a multipurpose gym with 8,000 feet that can hold three pickleball courts, two cross basketball courts, two volleyball courts and one main basketball court; a track that is 1/9-mile…